BackCalithera Biosciences Overview

Calithera Biosciences Current Cash

Calithera Biosciences's current cash is $25M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$25.45M
57.25% YoYΔ $-34.09M vs prior year quarter

Peer trimmed avg / median

Loading

Calithera Biosciences Current Cash History

Loading

Calithera Biosciences vs. peers: Current Cash Comparison

Loading

Calithera Biosciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Calithera Biosciences (CALA) FAQ

As of the most recent data (December 2022), CALA shows a current cash of $25M. That compares with $60M in the prior-year period — down 57.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CALA's current cash is now $25M (was $60M) — a 57.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Calithera Biosciences is outperforming or lagging.

Tracking CALA's current cash over time shows whether Calithera Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $25M That compares with $60M in the prior-year period — down 57.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Calithera Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $25M) with ownership activity and broader fundamentals.

Calithera Biosciences's current cash is $25M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.